Novel peptides as NS3-serine protease inhibitors of hepatitis C virus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20020068702A1
SERIAL NO

09909164

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses novel peptide compounds containing eleven amino acid residues which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such peptides as well as methods of using them to treat disorders associated with the HCV protease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DENDREON PHARMACEUTICALS INC400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brunck, Terrence K Santa Fe, NM 1 21
Levy, Odile E San Diego, CA 8 87
Lim-Wilby, Marguerita La Jolla, CA 13 403

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation